BAXFENDY
Live / Allowed — Notice of allowance issued (as of 06 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 Oct 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98779742
- Mark type
- Stylized text
- Filed
- 01 Oct 2024
- Published for opposition
- 11 Nov 2025
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cardiovascular, renal, and metabolic diseases and disorders
Owner
- AstraZeneca Ireland Limited, Dublin 15, IE
- AstraZeneca Ireland Limited, Dublin 15, IE
Prosecution history
- 21 Jan 2026 — TEAS DELETE 1(B) BASIS RECEIVED
- 06 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Nov 2025 — PUBLISHED FOR OPPOSITION
- 05 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 11 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 24 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Mar 2025 — NON-FINAL ACTION E-MAILED
- 24 Mar 2025 — NON-FINAL ACTION WRITTEN
- 19 Mar 2025 — ASSIGNED TO EXAMINER